• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sana Biotechnology Inc (NQ: SANA )

    4.065 -0.015 (-0.37%)
    Streaming Delayed Price Updated: 11:51 AM EDT, Oct 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Sana Biotechnology Inc

    < Previous 1 2 3 4 Next >
    Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Sana Biotechnology to Present at September 2024 Investor Conferences
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Why Sana Biotechnology Shares Are Rising Today
    Sana Biotechnology, Inc. (NASDAQ: SANA) announced the U.S. 
    Via Benzinga
    SANA Stock Earnings: Sana Biotechnology Misses EPS for Q2 2024
    SANA stock results show that Sana Biotechnology missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    SANA Stock Earnings: Sana Biotechnology Meets EPS for Q1 2024
    SANA stock results show that Sana Biotechnology met analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology to Present at May and June 2024 Investor Conferences
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
    U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
    U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
    Via Benzinga
    Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    PayPal Reports Q4 Results, Joins Rapid7, GoPro And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 10 points on Thursday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Sana Biotechnology Announces Pricing of Upsized Public Offering
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Sana Biotechnology Announces Proposed Public Offering of Common Stock
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    A look at five stocks seeing increased attention from investors. 
    Via Benzinga
    Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
    U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
    Expect to disclose initial SC262 clinical data in 2024 
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.